时间标签：数据日期 2026-11-03 · 生成时间 2026-11-03 05:30（Asia/Shanghai）｜ 检索窗口 PubMed edat 2026/10/31 – 2026/11/03 ｜ 情报发生日期 2026-11-03
证据级别：摘要级。本条依据 PubMed 结构化摘要与元数据撰写，付费墙全文未获取、未逐节核验，本站未做任何数值推算补全。
摘要（PubMed 原文节选）
As the aging population grows, the prevalence of dementia continues to increase, creating an urgent need for preventive strategies. ETAS, a standardized extract of Asparagus officinalis stem, has been shown to influence brain functions such as stress reduction and autonomic regulation. However, its specific effects on cognitive functions remain unclear. This randomized, double-blind, placebo-controlled trial investigated the effects of ETAS on cognitive function in healthy adults. Sixty-six adults aged ≥40 y with normal cognitive function (Japanese version of the Mini-Mental State Examination [MMSE-J] ≥24) were randomly assigned to receive 300 mg/d of ETAS or placebo for 12 wk. A comprehensi…
对本项目的价值
参考价值：属「脑老化与认知轨迹」方向；干预策略与临床试验栏目可用作本项目文献库与综述素材。 ｜ 价值分 2.0/5（★★☆☆☆）
全文不可及原因
标注 OA 但 PDF 下载失败或未通过题名指纹归属校验
原文题录
- 中文题名：摄入 ETAS 改善健康中老年人认知功能：随机双盲安慰剂对照试验
- 英文标题：Intake of ETAS® Improves Cognitive Function in Healthy Middle-Aged and Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial.
- 期刊与标识：J Nutr Sci Vitaminol (Tokyo) · PMID 42968246 · DOI 10.3177/jnsv.72.415 · EDAT 2026-11-01